{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:28:22Z","timestamp":1786768102220,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.actatropica.2026.108246","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:02:59Z","timestamp":1784732579000},"page":"108246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Next-generation sequencing reveals major and minority HIV-1 drug resistance mutations in treatment-experienced individuals with virological failure"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-2091","authenticated-orcid":false,"given":"Rodrigo Lopes Sanz","family":"Duro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Claudio Santana","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Funayama","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira C\u00edcero","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Galinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-1464","authenticated-orcid":false,"given":"Junior Olimpio","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-7601","authenticated-orcid":false,"given":"Ricardo","family":"Dur\u00e3es-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Sobhie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Vasconcelos","family":"Komninakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.actatropica.2026.108246_bib0001","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.02568-12","article-title":"Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness","volume":"57","author":"Abram","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-017-0360-7","article-title":"HIV drug resistance against strand transfer integrase inhibitors","volume":"14","author":"Anstett","year":"2017","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.actatropica.2026.108246_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/v12060617","article-title":"Next-generation sequencing for HIV drug resistance testing: laboratory, clinical, and implementation considerations","volume":"12","author":"\u00c1vila-R\u00edos","year":"2020","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.actatropica.2026.108246_bib0004","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMp1710608","article-title":"HIV drug resistance\u2014An emerging threat to epidemic control","volume":"377","author":"Beyrer","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2026.108246_bib0005","series-title":"Minist\u00e9rio Da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST, Aids e Hepatites Virais. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas Para Manejo da Infec\u00e7\u00e3o pelo HIV Em Adultos","year":"2013"},{"issue":"7","key":"10.1016\/j.actatropica.2026.108246_bib0007","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-200305020-00016","article-title":"Brazilian network for HIV drug resistance surveillance (HIV-BResNet): a survey of chronically infected individuals","volume":"17","author":"Brindeiro","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","article-title":"The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic","volume":"85","author":"Broder","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.actatropica.2026.108246_bib0009","article-title":"A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral na\u00efve Brazilian people with HIV","volume":"52","author":"Caldeira","year":"2025","journal-title":"Lancet Regional. Health - Am."},{"issue":"2","key":"10.1016\/j.actatropica.2026.108246_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ympev.2011.11.019","article-title":"The evolution of HIV: inferences using phylogenetics","volume":"62","author":"Castro-Nallar","year":"2012","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.actatropica.2026.108246_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/srep35779","article-title":"Prevalence of integrase strand transfer inhibitor resistance mutations","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2026.108246_bib0012","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijid.2020.02.004","article-title":"Variable performance of Sanger sequencing revealed by deep sequencing","volume":"93","author":"Chen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108246_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect. Genet. Evol."},{"issue":"8","key":"10.1016\/j.actatropica.2026.108246_bib0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/aid.2017.0135","article-title":"Prevalence of rilpivirine and etravirine resistance mutations","volume":"34","author":"Diphoko","year":"2018","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.actatropica.2026.108246_bib0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12977-014-0122-8","article-title":"Cross-clade simultaneous HIV drug resistance genotyping by Illumina MiSeq","volume":"11","author":"Dudley","year":"2014","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.actatropica.2026.108246_bib0017","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug-resistant HIV","volume":"202","author":"Gianella","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2026.108246_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94542-5","article-title":"HIV-1 molecular diversity in Brazil unveiled by 10 years of sampling by the Brazilian network for HIV Genotyping","volume":"11","author":"Gr\u00e4f","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2012.08.048","article-title":"The increasing prevalence of HIV-1 subtype C in Southern Brazil and its dispersion through the continent","volume":"435","author":"Gr\u00e4f","year":"2013","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.actatropica.2026.108246_bib0020","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2352-3018(18)30173-5","article-title":"HIV drug resistance in low-income and middle-income countries","volume":"5","author":"Hamers","year":"2018","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.actatropica.2026.108246_bib0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","article-title":"Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis","volume":"19","author":"Hemelaar","year":"2019","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"10.1016\/j.actatropica.2026.108246_bib0022","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1016\/S2352-3018(20)30252-6","article-title":"Global and regional epidemiology of HIV-1 recombinants in 1990\u20132015: a systematic review and global survey","volume":"7","author":"Hemelaar","year":"2020","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.actatropica.2026.108246_bib0023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","article-title":"The origin and diversity of the HIV-1 pandemic","volume":"18","author":"Hemelaar","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.actatropica.2026.108246_bib0024","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3018(18)30177-2","article-title":"Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study","volume":"5","author":"Inzaule","year":"2018","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.actatropica.2026.108246_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/v12060586","article-title":"Are we ready for NGS HIV drug resistance testing? The second \u201cWinnipeg Consensus\u201d symposium","volume":"12","author":"Ji","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.actatropica.2026.108246_bib0026","first-page":"156","article-title":"2011 update of the drug resistance mutations in HIV-1","volume":"19","author":"Johnson","year":"2011","journal-title":"Top Antivir. Med."},{"issue":"2","key":"10.1016\/j.actatropica.2026.108246_bib0027","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jmv.25245","article-title":"Epidemiology of HIV drug resistance","volume":"91","author":"Karkashadze","year":"2019","journal-title":"J. Med. Virol."},{"issue":"13","key":"10.1016\/j.actatropica.2026.108246_bib0028","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of virologic failure","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.actatropica.2026.108246_bib0029","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/aid.2019.0242","article-title":"Genetic diversity of HIV-1 quasispecies","volume":"36","author":"Liu","year":"2020","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209605","article-title":"Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 seroconverter study cohort","volume":"14","author":"Machnowska","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.actatropica.2026.108246_bib0031","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jgar.2019.08.024","article-title":"Transmitted drug resistance mutations","volume":"20","author":"Mazzuti","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"3","key":"10.1016\/j.actatropica.2026.108246_bib0032","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.idc.2019.05.004","article-title":"Management of virologic failure and HIV drug resistance","volume":"33","author":"McCluskey","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"8","key":"10.1016\/j.actatropica.2026.108246_bib0033","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jac\/dkq205","article-title":"Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping","volume":"65","author":"Monleau","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0034","article-title":"Comparison between next-generation and Sanger sequencing","volume":"20","author":"Moscona","year":"2017","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12985-016-0628-x","article-title":"Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?","volume":"13","author":"Mzingwane","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.actatropica.2026.108246_bib0036","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3389\/fmicb.2015.01258","article-title":"Quasispecies analyses of the HIV-1 near-full-length genome with Illumina MiSeq","volume":"6","author":"Ode","year":"2015","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0037","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-022-07453-9","article-title":"HIV-1 drug resistance genotyping success rates and correlates of dried-blood spots and plasma specimen genotyping failure in a resource-limited setting","volume":"22","author":"Omooja","year":"2022","journal-title":"BMC Infect Dis."},{"issue":"5","key":"10.1016\/j.actatropica.2026.108246_bib0038","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/505711","article-title":"Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level","volume":"194","author":"Parikh","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.actatropica.2026.108246_bib0039","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e3281ac229b","article-title":"Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase","volume":"21","author":"Parikh","year":"2007","journal-title":"Aids"},{"issue":"6518","key":"10.1016\/j.actatropica.2026.108246_bib0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/374124b0","article-title":"Recombination in HIV-1","volume":"374","author":"Robertson","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.actatropica.2026.108246_bib0041","first-page":"67","article-title":"HIV-1 drug resistance mutations: an updated framework for the second decade of HAART","volume":"10","author":"Shafer","year":"2008","journal-title":"AIDS Rev."},{"issue":"10","key":"10.1016\/j.actatropica.2026.108246_bib0042","doi-asserted-by":"crossref","first-page":"ofz377","DOI":"10.1093\/ofid\/ofz377","article-title":"Resistance in patients failing integrase inhibitors","volume":"6","author":"Steegen","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"suppl_9","key":"10.1016\/j.actatropica.2026.108246_bib0043","doi-asserted-by":"crossref","first-page":"S847","DOI":"10.1093\/infdis\/jix430","article-title":"The role of HIV-1 drug-resistant minority variants in treatment failure","volume":"216","author":"Stella-Ascariz","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.actatropica.2026.108246_bib0044","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijantimicag.2019.02.007","article-title":"Resistance to doravirine","volume":"53","author":"Sterrantino","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13104-020-05151-w","article-title":"Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin","volume":"13","author":"Tchiakpe","year":"2020","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.actatropica.2026.108246_bib0046","first-page":"49","article-title":"Profile of etravirine for the treatment of HIV infection","volume":"6","author":"Tseng","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure","volume":"9","author":"Vandenhende","year":"2014","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.actatropica.2026.108246_bib0049","first-page":"111","article-title":"2019 update of HIV-1 drug resistance mutations","volume":"27","author":"Wensing","year":"2019","journal-title":"Top. Antivir. Med."},{"issue":"4","key":"10.1016\/j.actatropica.2026.108246_bib0050","first-page":"559","article-title":"2022 update of the drug resistance mutations in HIV-1","volume":"30","author":"Wensing","year":"2022","journal-title":"Top. Antivir. Med."},{"issue":"1","key":"10.1016\/j.actatropica.2026.108246_bib0052","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vex003","article-title":"In vivo mutation rates and fitness landscape of HIV-1","volume":"3","author":"Zanini","year":"2017","journal-title":"Virus Evol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X26002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:05:49Z","timestamp":1786766749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X26002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0001706X26002792"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108246","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation sequencing reveals major and minority HIV-1 drug resistance mutations in treatment-experienced individuals with virological failure","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2026.108246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108246"}}